Depletion of IL5 following treatment with neutralizing anti-IL5 antibodies or crosses with IL5-deficient mice decreased the number of eosinophils, but did not ameliorate the dermatitis, suggesting a limited role for eosinophils in disease development [15]. This evidence concerns the gene IL5 and skin disorder.